{"id":"clm_47AF0CE8CA36","entity":"regeneron-pharmaceuticals","predicate":"quarterly_research_and_development","value":"507,435,000 United States dollar","value_json":{"fp":"Q1","fy":2017,"accn":"0001532176-17-000017","form":"10-Q","filed":"2017-05-04","period":"Q1 FY2017","concept":"us-gaap:ResearchAndDevelopmentExpense"},"valid_from":"2017-03-31","valid_to":"2017-06-30","published":"2017-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Regeneron Pharmaceuticals quarterly research and development: 507,435,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_47AF0CE8CA36, https://asof.is/claim/clm_47AF0CE8CA36, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217617000017/0001532176-17-000017-index.htm.","url":"https://asof.is/claim/clm_47AF0CE8CA36","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_F6A5C3C217BB","supersedes":["clm_B963E3479652"],"first_seen_at":"2026-11-08T17:08:55.512322+00:00","updated_at":"2026-11-08T17:08:58.955536+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/872589/000153217617000017/0001532176-17-000017-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2017","published_at":"2017-05-04T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2017, filed 2017-05-04"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}